Advances in Molecular Research in Pediatric Hematology
A special issue of Children (ISSN 2227-9067). This special issue belongs to the section "Pediatric Hematology & Oncology".
Deadline for manuscript submissions: 25 March 2025 | Viewed by 49
Special Issue Editor
Special Issue Information
Dear Colleagues,
It is a great honor to serve as the Guest Editor for this Special Issue of Children, entitled “Advances in Molecular Research in Pediatric Hematology”. Pediatric Hematology covers research, diagnosis, and treatment of blood disorders in children including anemia, clotting disorders, leukemia and lymphoma, and rare genetic disorders such as thalassemia and hemophilia.
The ever-increasing use of molecular research in clinics has led to significant improvements in prognosis and treatment outcomes. Recent advances in next-generation sequencing (NGS) have enabled the identification of novel genetic mutations and biomarkers associated with various pediatric blood disorders. Additionally, advancements in gene therapy and CRISPR-Cas9 gene editing offer promising therapeutic avenues.
The aim of this Special Issue is to explore advancements in molecular research that enhance our understanding of blood disorders in children. We invite investigators to submit original research articles and review articles that will inspire ongoing efforts to deepen knowledge in this challenging field.
Please submit your research to this Special Issue.
Dr. Praveen Kumar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Children is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pediatric hematology
- molecular research
- blood disorders
- anemia
- leukemia
- gene therapy
- CRISPR-Cas9
- next-generation sequencing (NGS)
- genetic mutations
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
